DEA Should “Reject” Arguments that Rescheduling Marijuana Violates International Treaties, Says Congressmember

Congresswoman Sydney Kamlager-Dove (CA-37) has sent a letter to the Drug Enforcement Administration (DEA) urging them to reject any argument in support of maintaining marijuana in Schedule I or Schedule II based on U.S. Treaty obligations.

This letter is in response to a former letter from the DEA, which stated that the Administration would conduct a review of the Department of Health and Human Services’ (HHS) recommendation to reschedule marijuana from a Schedule I to a Schedule III drug under the Controlled Substances Act (CSA), states a press release.

The letter emphasizes that applicable Treaties neither require the U.S. to keep marijuana in Schedule I or II nor do they preclude the DEA from accepting HHS’s recommendation.

“I write to urge you to reject any argument in support of maintaining marijuana in Schedule I or Schedule II based on U.S. Treaty obligations.  Applicable Treaties neither require the U.S. to keep marijuana in Schedule I or II nor do they preclude the DEA from accepting HHS’s recommendation,” the Congresswoman wrote. “Cannabis should be removed from the Controlled Substances Act (CSA) schedule entirely; however, I acknowledge that the rescheduling of cannabis is a historic first step to addressing the harms of the War on Drugs, which is why I want to ensure that U.S. Treaties are not considered as a potential reason against rescheduling or de-scheduling marijuana.”

“Rescheduling marijuana to Schedule III is a welcomed move towards mitigating the devastating impacts that marijuana’s place on the CSA has caused,” wrote the Congresswoman. “As an advocate for the removal of marijuana from the CSA, I recognize that rescheduling serves as an initial stride toward achieving the ultimate goal of decriminalization. Therefore, at minimum, I ask that you follow HHS recommendations and reschedule marijuana to Schedule III and reject any argument in support of maintaining marijuana in Schedule I or Schedule II based on U.S. Treaty obligations… As an advocate for the removal of marijuana from the CSA, I recognize that rescheduling serves as an initial stride toward achieving the ultimate goal of decriminalization. Therefore, at minimum, I ask that you follow HHS recommendations and reschedule marijuana to Schedule III and reject any argument in support of maintaining marijuana in Schedule I or Schedule II based on U.S. Treaty obligations.”

The letter concludes by asking the DEA to respond to the following questions at their earliest convenience.

  1. Is it the DEA’s position that applicable treaty obligations preclude the agency from adopting HHS’s recommendation to transfer marijuana to Schedule III?
  2. Who has attempted to influence the DEA’s views on applicable treaty obligations and the proposed reclassification of marijuana? Please provide a log of all meetings DEA staff have taken with outside partners on this matter.
  3. Has the DEA consulted with the U.S. Department of State or any expert agency outside of the U.S. Department of Justice regarding treaty obligations and the pending administrative process to reconsider marijuana’s Schedule I classification?

To read the full letter click here.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

 

 

More articles from The Marijuana Herald can be found below.

Ohio Now Has 186 Licensed Marijuana Stores, With 95 More in Provisional Status

Ohio Now Has 186 Licensed Marijuana Stores, With 95 More in Provisional Status

Florida Representative Files Bill to Tighten Medical Marijuana Rules and Expand Health Programs

Florida Representative Files Bill to Tighten Medical Marijuana Rules and Expand Health Programs

U.S. Senate Bill Would Create National Framework for Hemp-Derived Cannabinoids, Limit Products to 5mg THC Per Serving

U.S. Senate Bill Would Create National Framework for Hemp-Derived Cannabinoids, Limit Products to 5mg THC Per Serving

Florida GOP Lawmaker Files Bill to Expand Medical Marijuana Access, Increase Supply Limits, and Loosen Key Restrictions

Florida GOP Lawmaker Files Bill to Expand Medical Marijuana Access, Increase Supply Limits, and Loosen Key Restrictions

Connecticut Marijuana Sales Top $257 Million in 2025, Price Per Gram in November Drops Below $8 for First Time

Connecticut Marijuana Sales Top $257 Million in 2025, Price Per Gram in November Drops Below $8 for First Time

New Jersey Cannabis Commission to Hold Virtual Meetings on How Social Equity Excise Fee Dollars Should Be Spent

New Jersey Cannabis Commission to Hold Virtual Meetings on How Social Equity Excise Fee Dollars Should Be Spent

Ohio Senate Approves Bill to Overhaul State’s Marijuana Laws, Including Criminalizing Public Use and Establishing Hemp Restrictions

Ohio Senate Approves Bill to Overhaul State’s Marijuana Laws, Including Criminalizing Public Use and Establishing Hemp Restrictions

New Hampshire: Bipartisan Coalition of Lawmakers Introduce Constitutional Amendment to Guarantee Those 21+ the Right to Possess Marijuana

New Hampshire: Bipartisan Coalition of Lawmakers Introduce Constitutional Amendment to Guarantee Those 21+ the Right to Possess Marijuana

Cannabix Technologies’ Marijuana Breath Test Device Clears Key U.S. and Canadian Regulatory Hurdle

Cannabix Technologies’ Marijuana Breath Test Device Clears Key U.S. and Canadian Regulatory Hurdle

Cronos Group to Acquire Europe’s Largest Adult-Use Cannabis Company in $67 Million Deal

Cronos Group to Acquire Europe’s Largest Adult-Use Cannabis Company in $67 Million Deal

Minnesota’s “Open Package” Marijuana Law Has Fueled Thousands of New Charges Since Legalization

Minnesota’s “Open Package” Marijuana Law Has Fueled Thousands of New Charges Since Legalization

Montana Cannabis Sales Top $26 Million in November, Pushing Year-to-Date Total to $300 Million

Montana Cannabis Sales Top $26 Million in November, Pushing Year-to-Date Total to $300 Million

Safe Harbor Financial Announces “Major Banking Win” With Canopy HR, Launches New Cashflow Tool for Cannabis Businesses

Safe Harbor Financial Announces “Major Banking Win” With Canopy HR, Launches New Cashflow Tool for Cannabis Businesses

The Cheapest Legal Cannabis Prices as of December 2025: Oregon Leads, Followed Closely by Michigan and Massachusetts

The Cheapest Legal Cannabis Prices as of December 2025: Oregon Leads, Followed Closely by Michigan and Massachusetts

Florida Lawmaker Introduces Bill Shielding Employers From Civil Liability in Marijuana-Related Employment Actions

Florida Lawmaker Introduces Bill Shielding Employers From Civil Liability in Marijuana-Related Employment Actions

New Jersey Senate Committee Advances Bill Overhauling Cannabis Commission Rules and Expanding Dispensary Licensing

New Jersey Senate Committee Advances Bill Overhauling Cannabis Commission Rules and Expanding Dispensary Licensing

New York Governor Forces Out Cannabis Director Amid Enforcement Turmoil

New York Governor Forces Out Cannabis Director Amid Enforcement Turmoil

Study: Tailored Full-Spectrum Marijuana Extracts Linked to Broad Benefits for Women With Chronic Pain

Study: Tailored Full-Spectrum Marijuana Extracts Linked to Broad Benefits for Women With Chronic Pain